Pharmaceuticals Malaysia

Malaysia Menopause Treatment Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Malaysia Menopause Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Symptom, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Malaysia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $32.1 Mn Placeholder estimate
Estimate 2025 $34.0 Mn 0.2% of the global market
Projected 2034 $56.9 Mn 67.5% Adds $22.9 Mn over 9 forecast years
CAGR 2025–2034 5.9% Faster than 20% of 180 Pharmaceuticals markets here
Key players 6 +1
  • Malaysia is 0.19% of the global market.
  • In APAC, the largest is China at $1.48 Bn.
  • Fastest growing: India at 8.8% a year.
  • Malaysia ranks 7th of 10 by size in APAC.

Market size projection

Malaysia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$22.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Menopause Treatment Market market size by year, Malaysia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $32.1 Mn — —
2025 (base) $34.0 Mn +$1.9 Mn —
2026 (forecast) $36.0 Mn +$2.0 Mn +5.9%
2027 (forecast) $38.1 Mn +$2.1 Mn +12.1%
2028 (forecast) $40.4 Mn +$2.2 Mn +18.8%
2029 (forecast) $42.7 Mn +$2.4 Mn +25.8%
2030 (forecast) $45.3 Mn +$2.5 Mn +33.2%
2031 (forecast) $47.9 Mn +$2.7 Mn +41.1%
2032 (forecast) $50.8 Mn +$2.8 Mn +49.4%
2033 (forecast) $53.8 Mn +$3.0 Mn +58.2%
2034 (forecast) $56.9 Mn +$3.2 Mn +67.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $18.36 Bn
  2. North America $8.49 Bn
  3. US $7.84 Bn
  4. Europe $3.72 Bn
  5. APAC $3.80 Bn
  6. Canada $1.63 Bn
  7. China $1.48 Bn
  8. Japan $1.14 Bn
  9. Middle East $835.9 Mn
  10. Latin America $753.5 Mn
  11. Germany $565.2 Mn
  12. France $541.0 Mn
  13. UK $496.9 Mn
  14. Brazil $513.5 Mn
  15. Spain $383.2 Mn
  16. Ecuador $397.0 Mn
  17. Italy $383.0 Mn
  18. Saudi Arabia $353.0 Mn
  19. India $343.5 Mn
  20. Mexico $256.7 Mn
  21. Australia $247.5 Mn
  22. Africa $242.8 Mn
  23. Russia $205.5 Mn
  24. New Zealand $186.8 Mn
  25. South Africa $140.3 Mn
  26. UAE $100.8 Mn
  27. Egypt $52.4 Mn
  28. Philippines $44.7 Mn
  29. Malaysia (this report) $34.0 Mn
  30. Hong Kong $27.7 Mn
  31. Thailand $21.9 Mn
  32. Singapore $19.3 Mn
  33. Kenya $12.3 Mn

Report snapshot

Malaysia Menopause Treatment Market Analysis at a glance
Market size, 2025$34.0 Mn placeholder estimate
Forecast, 2034$56.9 Mn placeholder estimate
Growth (CAGR), 2025–20345.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTreatment, symptom and end user (see all)
Key playersAstellas Pharma Inc., Bayer AG, Pfizer Inc., Novo Nordisk A/S, TherapeuticsMD and 1 more (see all)
Regulator in MalaysiaNPRASource: National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Malaysia Menopause Treatment Market Analysis Executive Summary

Menopause treatment relieves symptoms such as hot flashes, sleep problems and bone loss with hormone therapy, non-hormonal medicines and supplements.

Key segments of the menopause Treatment market include treatment (Hormone Replacement Therapy, Non-Hormonal Drugs and NK3 Receptor Antagonists) and symptom (Vasomotor Symptoms, Vaginal Atrophy and Osteoporosis).

Bar chart: Malaysia Menopause Treatment market size, 2024–2034, placeholder estimates. $32.1 Mn in 2024, $34.0 Mn in 2025 and $56.9 Mn in 2034, 5.9% CAGR.
Malaysia Menopause Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Malaysia Menopause Treatment Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the menopause Treatment market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the menopause Treatment market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the menopause Treatment market.

Competitive Landscape for Menopause Treatment Market in Malaysia

The menopause Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Menopause Treatment Market in Malaysia

Menopause Treatment in Malaysia: rules and payment

Medicines must be registered with the Drug Control Authority, which works through the National Pharmaceutical Regulatory Agency (NPRA).⁠[1] Public clinics and hospitals run by the Ministry of Health give heavily subsidised care.⁠[2]

[1] National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026.

[2] Ministry of Health Malaysia. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for menopause Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Malaysia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Menopause Treatment right now, from free public sources.

Latest research 28 papers since 2021 (worldwide)

  1. Factors associated with receipt of prescription medication for menopause-related symptoms. Menopause (New York, N.Y.), 2026
  2. A mobile app compared with an educational pamphlet on menopause hormone therapy initiation: a randomized pilot study. Frontiers in reproductive health, 2026
  3. Menopause and epigenetic changes: a review. Climacteric : the journal of the International Menopause Society, 2026
  4. Menopause experience among people with criminal legal system involvement. Menopause (New York, N.Y.), 2026
  5. Physical Exercise Enhances Melatonin Effect in D-Galactose/Aluminum Chloride-Induced Alzheimer's Disease of Ovariectomized Rats: Irisin Induction Associated with Upregulation of PPAR-γ/IGF-1/BDNF and Decreasing TNF-α/p38-MAPK/NLRP3/GFAP Pathway. Pharmaceuticals (Basel, Switzerland), 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Menopause Treatment in context

Malaysia compared

  • Health spending per person: 450 US$ per person (2023). World: 1,317 US$ per person (2023). 6th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.34 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 6th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 8.0% of people (2025). World: 10.4% of people (2025). 8th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Menopause Treatment market in Malaysia?
Placeholder estimate: about $34.0 Mn in 2025, rising to about $56.9 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Menopause Treatment market in Malaysia growing?
Placeholder estimate: about 5.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Menopause Treatment market report cover?
The report splits the market by treatment (Hormone Replacement Therapy, Non-Hormonal Drugs, NK3 Receptor Antagonists, Supplements), symptom (Vasomotor Symptoms, Vaginal Atrophy, Osteoporosis, Sleep and Mood) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Menopause Treatment market?
Key players include Astellas Pharma Inc., Bayer AG, Pfizer Inc., Novo Nordisk A/S, TherapeuticsMD and Mithra Pharmaceuticals.
What is driving the Menopause Treatment market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the menopause Treatment market. New products designed around women's biology and digital care are improving access.
Who regulates Menopause Treatment in Malaysia?
Medicines must be registered with the Drug Control Authority, which works through the National Pharmaceutical Regulatory Agency (NPRA). Source: National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026.
How is healthcare paid for in Malaysia?
Public clinics and hospitals run by the Ministry of Health give heavily subsidised care. Source: Ministry of Health Malaysia. Checked 14 Nov 2026.
How much research is published on Menopause Treatment?
PubMed lists 28 papers on Menopause Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Menopause Treatment in Malaysia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Breast Cancer Screening and Diagnosis: Closing the GapBreast cancer is the most common cancer in women worldwide. Finding it early saves lives, but access to… Fertility Services: Rising Demand and Access GapsAbout 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income.
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Malaysia

See all
Same topic, other categories

Related on women's health

See the topic